BridgeMD
Compares treatment options for Coronary Artery Atherosclerosis
Official title Radial vs Vena No-Touch Assessment
ClinicalTrials.gov ID: NCT07552948
What this study is testing
- What it's testing
- This study examines the outcomes of coronary artery bypass grafting (CABG) in women at 1 year after surgery. A randomized controlled trial is planned, including a comparative analysis of two observed groups depending on the chosen conduit for revascularization of the circumflex artery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Three-vessel disease involving the target circumflex artery with stenosis ≥70% and a diameter ≥1.5 mm
- Females aged 18 years and older
- Signed informed consent
- Clinical indications for coronary revascularization (refractory angina/transient myocardial ischemia according to noninvasive tests)
You likely can't join if
- Previous cardiac surgery of any type, including CABG
- Combined procedures
- Ineligibility for venous or radial artery harvesting as determined by preoperative Doppler flowmetry or clinical examination that would compromise...
- Acute myocardial ischemia
- EF less than 35%
- CKD 4.5
See the full eligibility criteria
- Three-vessel disease involving the target circumflex artery with stenosis ≥70% and a diameter ≥1.5 mm
- Females aged 18 years and older
- Signed informed consent
- Clinical indications for coronary revascularization (refractory angina/transient myocardial ischemia according to noninvasive tests)
- Previous cardiac surgery of any type, including CABG
- Combined procedures
- Ineligibility for venous or radial artery harvesting as determined by preoperative Doppler flowmetry or clinical examination that would compromise graft patency.
- Acute myocardial ischemia
- EF less than 35%
- CKD 4.5
- Inability to understand the nature, scope, and consequences of the clinical trial, or to provide written informed consent due to cognitive impairment or mental illness.
- Life expectancy less than 1 year due to non-cardiac diseases.
The study team makes the final eligibility decision.
Where it's taking place
- Tomsk, Russia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tomsk, Russia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.